Matthew J O'Neill,Chai-Ann Ng,Takanori Aizawa,Luca Sala,Sahej Bains,Annika Winbo,Rizwan Ullah,Qianyi Shen,Chek-Ying Tan,Krystian Kozek,Loren R Vanags,Devyn W Mitchell,Alex Shen,Yuko Wada,Asami Kashiwa,Lia Crotti,Federica Dagradi,Giulia Musu,Carla Spazzolini,Raquel Neves,J Martijn Bos,John R Giudicessi,Xavier Bledsoe,Eric R Gamazon,Megan C Lancaster,Andrew M Glazer,Bjorn C Knollmann,Dan M Roden,Jochen Weile,Frederick Roth,Joe-Elie Salem,Nikki Earle,Rachael Stiles,Taylor Agee,Christopher N Johnson,Minoru Horie,Jonathan Skinner,Michael J Ackerman,Peter J Schwartz,Seiko Ohno,Jamie I Vandenberg,Brett M Kroncke

Abstract:Background: Long QT syndrome is a lethal arrhythmia syndrome, frequently caused by rare loss-of-function variants in the potassium channel encoded by KCNH2. Variant classification is difficult, often because of lack of functional data. Moreover, variant-based risk stratification is also complicated by heterogenous clinical data and incomplete penetrance. Here we sought to test whether variant-specific information, primarily from high-throughput functional assays, could improve both classification and cardiac event risk stratification in a large, harmonized cohort of KCNH2 missense variant heterozygotes. Methods: We quantified cell-surface trafficking of 18 796 variants in KCNH2 using a multiplexed assay of variant effect (MAVE). We recorded KCNH2 current density for 533 variants by automated patch clamping. We calibrated the strength of evidence of MAVE data according to ClinGen guidelines. We deeply phenotyped 1458 patients with KCNH2 missense variants, including QTc, cardiac event history, and mortality. We correlated variant functional data and Bayesian long QT syndrome penetrance estimates with cohort phenotypes and assessed hazard ratios for cardiac events. Results: Variant MAVE trafficking scores and automated patch clamping peak tail currents were highly correlated (Spearman rank-order ρ=0.69; n=433). The MAVE data were found to provide up to pathogenic very strong evidence for severe loss-of-function variants. In the cohort, both functional assays and Bayesian long QT syndrome penetrance estimates were significantly predictive of cardiac events when independently modeled with patient sex and adjusted QT interval (QTc); however, MAVE data became nonsignificant when peak tail current and penetrance estimates were also available. The area under the receiver operator characteristic curve for 20-year event outcomes based on patient-specific sex and QTc (area under the curve, 0.80 [0.76-0.83]) was improved with prospectively available penetrance scores conditioned on MAVE (area under the curve, 0.86 [0.83-0.89]) or attainable automated patch clamping peak tail current data (area under the curve, 0.84 [0.81-0.88]). Conclusions: High-throughput KCNH2 variant MAVE data meaningfully contribute to variant classification at scale, whereas long QT syndrome penetrance estimates and automated patch clamping peak tail current measurements meaningfully contribute to risk stratification of cardiac events in patients with heterozygous KCNH2 missense variants.

Case Report: A novel KNCH2 variant-induced fetal heart block and the advantages of fetal genomic sequencing in prenatal long-term dexamethasone exposure

A Rare Case with Fetal Autoimmune Heart Block and KNCH2 Variant–induced Long QT Syndrome: a Controversial Opinion on Prenatal Management Strategy

Case Report: Biventricular Noncompaction Cardiomyopathy With Pulmonary Stenosis and Bradycardia in a Fetus With KCNH2 Mutation

Case Report: Prenatal Diagnosis and Treatment of Fetal Autoimmune-Associated First-Degree Atrioventricular Block: First Report From China

Low foetal heart rate, a potentially ominous finding: case report

Case Report: A Compound Heterozygous Mutations in ASNS Broadens the Spectrum of Asparagine Synthetase Deficiency in the Prenatal Diagnosis

The Combined Novel KCNQ1 Frameshift I145Sfs*92 and Nonsense W392X Variants Caused Jervell and Lange-Nielsen Syndrome in a Chinese Infant Presenting with Sustained Foetal Bradycardia

Prenatal detection of novel compound heterozygous variants of the PLD1 gene in a fetus with congenital heart disease

Isolated non‐immune mediated second‐degree atrioventricular block in fetus: natural history and predictive factors for spontaneous recovery

Preventing and Treating Torsades de Pointes in the Mother, Fetus and Newborn in the Highest Risk Pregnancies with Inherited Arrhythmia Syndromes

Clinical Application of Chromosomal Microarray Analysis in Fetuses with Congenital Heart Disease

Prenatal Genetic Diagnosis in Three Fetuses With Left Heart Hypoplasia (LHH) From Three Unrelated Families

Digenic Heterozygous Mutations of KCNH2 and SCN5A Induced Young and Early‐onset Long QT Syndrome and Sinoatrial Node Dysfunction

Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome

Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation.

KCNH2 variants in a family with epilepsy and long QT syndrome: A case report and literature review

Targeted Next-Generation Sequencing Identifies Novel Compound Heterozygous Mutations of DYNC2H1 in a Fetus with Short Rib-Polydactyly Syndrome, Type III

Early Screening for Long QT Syndrome and Cardiac Anomalies in Infants: A Comprehensive Study

Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report

Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification

Prenatal genetic diagnosis of fetuses with dextrocardia using whole exome sequencing in a tertiary center